Literature DB >> 2335385

Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffee.

D C Farrow1, S Davis.   

Abstract

A population-based case-control study was conducted to examine the relationship between certain medical conditions, the use of tobacco, alcohol and coffee, and the incidence of pancreatic cancer. Cases (N = 148) were married men ages 20 through 74 years diagnosed with pancreatic cancer from July 1982 through June 1986. Controls (N = 188) were identified by random digit dialing. Wives, responding as surrogates for both cases and controls, were interviewed by telephone and completed, alone, a food frequency questionnaire. The risk of pancreatic cancer was increased in individuals with a history of diabetes or pancreatitis, and decreased in those with a history of tonsillectomy. Individuals who had ever smoked cigarettes were at elevated risk of disease. This excess risk was confined to current smokers, in whom the odds ratio was 3.2 (95% CI 1.8-5.7); the risk among former smokers resembled that in those who had never smoked. There was no excess risk of pancreatic cancer among those who had ever used other forms of tobacco, including pipe tobacco, cigars and chewing tobacco. After adjustment for demographic and dietary characteristics, there was no association between pancreatic cancer risk and the intake of coffee, beer, red wine, hard liquor or all alcohol combined; a slight reduction in risk was seen among those consuming white wine daily.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2335385     DOI: 10.1002/ijc.2910450504

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  37 in total

1.  Medical conditions in patients with pancreatic and biliary diseases: validity and agreement between data from questionnaires and medical records. PANKRAS II Study Group.

Authors:  M Soler; N Malats; M Porta; E Fernandez; L Guarner; A Maguire; J L Pinõl; J Rifà; A Carrato
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

2.  Diabetes and pancreatic cancer.

Authors:  Donghui Li
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

Review 3.  Cholecystectomy and the risk of alimentary tract cancers: a systematic review.

Authors:  Maria Coats; Sami M Shimi
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

4.  Risk of pancreatic cancer associated with cholelithiasis, cholecystectomy, or gastrectomy.

Authors:  L Gullo; R Pezzilli; A M Morselli-Labate
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 5.  Tobacco and the risk of pancreatic cancer: a review and meta-analysis.

Authors:  Simona Iodice; Sara Gandini; Patrick Maisonneuve; Albert B Lowenfels
Journal:  Langenbecks Arch Surg       Date:  2008-01-12       Impact factor: 3.445

6.  Risk of cancer in a large cohort of U.S. veterans with diabetes.

Authors:  Elizabeth A Atchison; Gloria Gridley; J Daniel Carreon; Michael F Leitzmann; Katherine A McGlynn
Journal:  Int J Cancer       Date:  2011-02-01       Impact factor: 7.396

7.  Risk of pancreatic cancer after cholecystectomy: a cohort study in Sweden.

Authors:  W Ye; J Lagergren; O Nyrén; A Ekbom
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

8.  Orthotopic inflammation-related pancreatic carcinogenesis in a wild-type mouse induced by combined application of caerulein and dimethylbenzanthracene.

Authors:  Chen Liang; Zhen Wang; Li Wu; Chen Wang; Bao-Hua Yu; Xiu-Zhong Yao; Xiao-Lin Wang; Ying-Yi Li
Journal:  Tumour Biol       Date:  2015-04-29

9.  Cigarette smoking and alcohol consumption and the risk of pancreatic cancer: a case-control study in Shanghai, China.

Authors:  B T Ji; W H Chow; Q Dai; J K McLaughlin; J Benichou; M C Hatch; Y T Gao; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1995-07       Impact factor: 2.506

10.  Alcohol use and risk of pancreatic cancer: the NIH-AARP Diet and Health Study.

Authors:  Li Jiao; Debra T Silverman; Catherine Schairer; Anne C M Thiébaut; Albert R Hollenbeck; Michael F Leitzmann; Arthur Schatzkin; Rachael Z Stolzenberg-Solomon
Journal:  Am J Epidemiol       Date:  2009-03-18       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.